The ginseng plants: commercial products and quality assessment

Hui Cao; Pui-Hay But Paul; Hu Shiu-Ying

doi:10.1007/BF02934844

Your Location：

Home >

Browse articles >

The ginseng plants: commercial products and quality assessment

Updated：2021-08-27

- The ginseng plants: commercial products and quality assessment
- Chinese Journal of Integrative Medicine Vol. 3, Issue 4, Pages: 306-310(1997)
- Affiliations：
  
  1. Institute of Chinese Materia Medica, China Academy of Tradition Chinese Medicine,Beijing
  2. Department of Biology and Chinese Medicinal Material Research Center, The Chinese University of Hong Kong,Hong Kong
  3. Arnold Arboretum, Harvard University,USA
- Author bio：
- Funds：
- DOI：10.1007/BF02934844
  CLC：
- Published：1997，
Scan for full text
Cao, H., Paul, PH.B. & Shiu-Ying, H. The ginseng plants: commercial products and quality assessment., CJIM 3, 306–310 (1997). https://doi.org/10.1007/BF02934844

Hui Cao, Pui-Hay But Paul, Hu Shiu-Ying. The ginseng plants: commercial products and quality assessment. [J]. Chinese Journal of Integrative Medicine 3(4):306-310(1997)
Cao, H., Paul, PH.B. & Shiu-Ying, H. The ginseng plants: commercial products and quality assessment., CJIM 3, 306–310 (1997). https://doi.org/10.1007/BF02934844 DOI：

Hui Cao, Pui-Hay But Paul, Hu Shiu-Ying. The ginseng plants: commercial products and quality assessment. [J]. Chinese Journal of Integrative Medicine 3(4):306-310(1997) DOI： 10.1007/BF02934844.

摘要

Abstract

关键词

GinsenosidesPanax GinsengMain RootAmerican GinsengGinseng Root

Keywords

GinsenosidesPanax GinsengMain RootAmerican GinsengGinseng Root

references

1994; 16(5): 46.

1983; 8(1): 34.

Kitagawa I, Taniyama T, Hayashi T, et al. Malonyl-gin-senosides Rb1, Rb2, Rc, and Rd, four new malonylated dammarane-type triterpene oligoglycodides from ginseng radix. Chem Pharm Bull 1983; 31: 3353.

Kitagawa I, Yoshikawa M, Yoshihara M, et al. Chemical studies on crude drug procession. I. On the constituents of ginseng radix rubra. Yakugaku Zasshi 1983; 103: 612.

Kasai R, Besso H, Tanaka O, et al. Saponins of red ginseng. Chem Pharm Bull 1983; 31: 2120.

Tanaka O, Kasai R and Morita T. Chemistry of ginseng and related plants: recent advances. Abst Chin Med 1986; 1: 130.

Lang WS, Lou ZC and But PPH. High-performance liquid chromatographic analysis ofginsenosides inPanax ginseng, P. quinquefolium andP. notoginseng. J Chin Pharm Sci, 1993, 2: 133

1989; 6: 286.

Cui J, Garle M, Eneroth P, et al. What do commercial ginseng proportions contain? Lancet 1994; 344: 134.

1997; 20: 534.

Chen X. Panax ginseng (Radix Ginseng) and ginsenosides. In: Zhou JH and Liu GZ (Eds.). Recent Advances in Chinese Herbal Drugs-Actions and Uses. Beijing and Brussels: Science Press and S. A. T. A. S. 1991: 91–99.

Shingh VK, Agarwal SS and Gupta BM. Immunomodulatory activity of Panax ginseng extract. Planta Med 1984; 50: 462.

1991, 16: 3.

1989; 20: 216.

1988; 14: 296.

Konno C, Sugiyama C, Kano K, et al. Isolation and hypoglycemic activity of panaxans A, B, C, D and E, Glycans of Panax ginseng roots. Planta Med 1984; 50: 434.

Tomoda M, Takeda T, Shimizu N, et al. Characterization of two acidic polysaccharides having immunological activities from the root of Panax ginseng. Biol Pharm Bull 1993; 16: 22.

Ahn BZ and Kim SI. Heptadeca-1, 8t-dien-4, 6-diin-3, 10-diol, ein weiteres, gegen L1210-Zellen cytotoxisches Wirkprinzip aus der Koreanaische Gindeng-wurzel. Planta Med 1988; 54: 183.

1990; 25: 401.

1990; 25: 727.

Liu Y, Liang W and Tu G. Perlolyrine: a β-carboline alkaloid from Codonopsis pilosula. Planta Med 1988; 54: 472.

Blasko G, Kardos J, Simonyi M, et al. Indole alkaloid β-carboline-1-propionic acid. Planta Med 1986, 51: 41.

Soldati F and Tanaka O. Panax ginseng: relation between age of plant and content of ginsenosides. Planta Med 1984; 50: 351.

Kubo M, Tani T, Katsuki T, et al. Histochemistry. I. Ginsenosides in ginseng (Panax ginseng C. A. Meyer, root). J Nat Prod 1980; 43: 278.

Tani T, Kubo M, Katsuki T, et al. Histochemistry. II. Ginsenosides in ginseng (Panax ginseng, root). J Nat Prod 1981; 44: 401.

FULL TEXT LINK

More>

Views

344

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Research and development of new Chinese materia medica for treatment of refractory hematopathy by establishment and application of multiple technique platforms

DNA profiling in authentication ofPanax plants and drugs: A new approach to old problems

DNA Molecular profiling: a new approach to quality control of chinese drugs

Influence of high blood glucose fluctuation on endothelial function of type 2 diabetes mellitus rats and effects of Panax Quinquefolius Saponin of stem and leaf

Orthostatic hypotension leading to recurrent syncope episodes in a hypertensive patient: Treatment with Tianma Gouteng Decoction (天麻钩藤饮)

Related Author

No data

Related Institution

Institute of Hematology, The First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine

Institute of Chinese Materia Medica, China Academy of Traditional Chinese Medicine

Research Center for Ethnomedicines, Institute of Natural Medicine, Toyama Medical and Pharmaceutical University

Department of Biology and Institute of Chinese Medicine, The Chinese University of Hong Kong

The Chinese University of Hong Kong, HKSAR

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰